FDA's use of guidance documents will be focus of Sept. 14 House hearing..
This article was originally published in The Rose Sheet
Executive Summary
FDA's USE OF GUIDANCE DOCUMENTS WILL BE FOCUS OF SEPT. 14 CONGRESSIONAL HEARING to be held jointly by two subcommittees of the House Government Reform Committee: Rep. Christopher Shays' (R-CT) Human Resources Subcommittee and Rep. David McIntosh's (R-IN) Regulatory Affairs Subcommittee. The hearing, which will address FDA enforcement issues, will examine the extent to which the agency requires compliance with guidance documents that are not promulgated as regulations.